1.5 Abstract in rivista
 Distribuzione geografica
Continente #
NA - Nord America 80.632
AS - Asia 48.351
EU - Europa 29.883
SA - Sud America 29.303
AF - Africa 1.769
OC - Oceania 184
Continente sconosciuto - Info sul continente non disponibili 161
AN - Antartide 2
Totale 190.285
Nazione #
US - Stati Uniti d'America 78.954
BR - Brasile 26.105
SG - Singapore 19.188
CN - Cina 15.571
UA - Ucraina 10.166
DE - Germania 4.310
SE - Svezia 4.277
HK - Hong Kong 3.954
VN - Vietnam 3.536
IT - Italia 2.733
FR - Francia 2.668
FI - Finlandia 1.765
GB - Regno Unito 1.282
AR - Argentina 1.119
TR - Turchia 818
BD - Bangladesh 679
IN - India 676
RU - Federazione Russa 621
IQ - Iraq 615
MX - Messico 581
CA - Canada 580
EC - Ecuador 543
ZA - Sudafrica 493
UZ - Uzbekistan 461
VE - Venezuela 393
PK - Pakistan 391
MA - Marocco 383
CO - Colombia 321
JP - Giappone 282
BE - Belgio 244
KR - Corea 229
PL - Polonia 223
ES - Italia 220
KE - Kenya 205
NL - Olanda 198
PY - Paraguay 196
UY - Uruguay 195
TN - Tunisia 188
ID - Indonesia 186
PE - Perù 172
CZ - Repubblica Ceca 171
JO - Giordania 171
CL - Cile 165
AZ - Azerbaigian 161
AU - Australia 155
DZ - Algeria 142
AE - Emirati Arabi Uniti 141
AT - Austria 122
NP - Nepal 121
EU - Europa 119
SA - Arabia Saudita 118
KZ - Kazakistan 107
EG - Egitto 105
DO - Repubblica Dominicana 97
OM - Oman 93
PH - Filippine 87
AL - Albania 85
IE - Irlanda 85
RS - Serbia 85
IR - Iran 83
JM - Giamaica 82
LT - Lituania 81
BO - Bolivia 80
IL - Israele 80
PS - Palestinian Territory 78
RO - Romania 77
KG - Kirghizistan 72
PA - Panama 71
LB - Libano 70
HN - Honduras 64
CR - Costa Rica 61
GE - Georgia 60
SN - Senegal 57
BY - Bielorussia 54
BG - Bulgaria 51
BH - Bahrain 45
GR - Grecia 43
NI - Nicaragua 40
AM - Armenia 36
MY - Malesia 36
CH - Svizzera 35
GT - Guatemala 33
XK - ???statistics.table.value.countryCode.XK??? 31
BA - Bosnia-Erzegovina 30
MD - Moldavia 30
AO - Angola 29
NG - Nigeria 29
NZ - Nuova Zelanda 29
PT - Portogallo 29
SK - Slovacchia (Repubblica Slovacca) 29
GA - Gabon 28
KW - Kuwait 28
SY - Repubblica araba siriana 28
BN - Brunei Darussalam 26
CI - Costa d'Avorio 26
QA - Qatar 25
DK - Danimarca 24
SV - El Salvador 24
HR - Croazia 23
HU - Ungheria 23
Totale 189.931
Città #
Dallas 28.106
Singapore 8.954
Chandler 8.735
Jacksonville 6.418
San Jose 5.388
Hong Kong 3.881
Dearborn 3.399
Princeton 3.348
Ashburn 3.308
Nanjing 2.923
Beijing 2.686
São Paulo 1.854
Lauterbourg 1.546
Wilmington 1.377
Ho Chi Minh City 1.272
Nanchang 1.117
Shanghai 1.106
Boardman 1.034
New York 924
Los Angeles 821
Ann Arbor 817
Hanoi 813
Rio de Janeiro 787
Belo Horizonte 711
Shenyang 673
Tianjin 617
Hebei 597
Santa Clara 591
Brasília 506
Changsha 491
Jiaxing 485
Sassari 419
Tashkent 414
Curitiba 379
Porto Alegre 364
Woodbridge 360
Buffalo 324
Campinas 304
Baghdad 297
Kunming 295
Munich 295
Guarulhos 276
San Francisco 271
Orem 264
Tokyo 263
Jinan 254
Salvador 252
Hangzhou 244
Norwalk 239
Brussels 235
Seoul 215
Johannesburg 210
Frankfurt am Main 208
Toronto 207
Helsinki 204
Rome 198
Goiânia 192
Warsaw 189
Guayaquil 184
Ribeirão Preto 182
Fortaleza 179
Nairobi 179
Montreal 168
Denver 166
Santo André 164
Istanbul 163
Quito 163
Dhaka 161
Amman 158
Montevideo 156
Chicago 155
Brooklyn 154
Baku 152
Guangzhou 152
Manaus 152
Recife 152
Atlanta 151
Sorocaba 151
Da Nang 150
Zhengzhou 150
Chennai 149
Caxias do Sul 147
Haiphong 146
São José dos Campos 145
London 144
Ningbo 138
Campo Grande 136
Uberlândia 133
Betim 130
Contagem 130
Stockholm 130
Joinville 128
Osasco 128
São José do Rio Preto 128
Brno 127
Nuremberg 127
Izmir 124
Mexico City 123
São Bernardo do Campo 122
Lima 121
Totale 108.855
Nome #
Occurrence of Xanthomonas arboricola pv. corylina on hazelnut orchards in Sardinia and Sicily 486
HETEROGENEITY OF TYPE 1 GASTRIC NEUROENDOCRINE NEOPLASMS 352
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 347
Reassessment of Proliferative Activity at Disease Progression in Neuroendocrine Neoplasms 344
Curative Resection in Digestive Neuroendocrine Neoplasms: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 342
FOLFOX Chemotherapy: Efficacy and Tolerability in Advanced Digestive Neuroendocrine Neoplasms (NENs) 339
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 337
Clinical Usefulness of Functional Imaging Tests in the Follow-Up of Digestive Neuroendocrine Neoplasms 331
Peritoneal Carcinomatosis in Digestive Neuroendocrine Neoplasms: Complications and Response to Therapy 330
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 328
Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 327
Accuracy of the Novel TNM Staging System in the Prognostic Stratification of Patients With Advanced, Stage IV Digestive Endocrine Tumors 327
Contrast Enhanced Ultrasonography (CEUS) and Quantitative Perfusion Analysis in the Assessment of Neuroendocrine Liver Metastases 327
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 322
Evaluation of Multidisciplinary Tumor Board Decisions in the Management of Neuroendocrine Tumors: Impact of Expert Centers 321
Role of Somatostatin Receptors scintigraphy in neuroendocrine neoplasms follow-up 319
REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS 314
Risk and Protective Factors for Midgut Carcinoid Tumours: Multicenter Case-Control Study of Prospectively Evaluated Patients 310
Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients 307
Histopathological Revision forGastroenteropancreatic NeuroendocrineNeoplasms in Expert Centers: Does It Make theDifference? 300
Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 293
Allelic Gains And Losses At 10q25-Q26 In Malignancies Of The Uterine Corpus: Demonstration Of Two Distinctive Genetic Alterations 281
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl 3-({[(5-hydroxy-4-oxo-4H-pyran-2- yl)methoxy]carbonyl}amino)propanoate. Synthesis and its complex formation study 277
A possible prognostic role for MSRV in multiple sclerosis. 270
Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma 270
123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease 266
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 266
Adherence to Acrysof intraocular lenses by organisms causing chronic postoperative endophthalmitis 261
A reappraisal of Multiple Sclerosis risk in Sardinians. 260
Abitudini di igiene orale in studenti universitari della città di Sassari. 253
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 248
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 247
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 241
A Case of Multiple Sclerosis and Hydrosyringomyelia: A Non-Coincidental Association? 240
Adhesion properties of ocular isolates of Staphylococcus epidermidis 239
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 237
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 237
123I FP-CIT SPECT in early Parkinson’s disease 229
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 229
APPLICATION OF 2009/127/EC AND 2009/128/EC DIRECTIVES IN SARDINIA (ITALY): RESULTS ON SPRAYING MACHINES 227
A reappraisal of multiple sclerosis risk among Sardinians. 225
123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease. 225
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders 223
123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia 223
Acquired hepatocerebral degeneration responsive to penicillamine: A case report 223
Akt down regulation by CYP2C9-induced ROS generation mediate dose-dependent cell damage elicited by natural antioxidants in human endothelial cells 220
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 219
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 217
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage. 217
A double-blind European Multicenter Study Evidences envelope protein from Human Endogenous Retrovirus W (MSRV-ENV or Syncytin) in serum from 73% of MS patients without selective clinical inclusion criteria 215
A Proteomic Approach To Characterize A Native Antigen Involved In Autoantibody Response In Multiple Sclerosis By A Structure-Based Designed Glycopeptide 210
Autoinflammatory diseases in Dermatology: a peculiar case of familial mediterranean fever 210
Application of proximal and remote sensing on precision viticulture in Sardinia (Italy) – Preliminary results 210
Abstracts from the IVECCS & EVECC Annual Congresses and the ACVECC VetCOT Veterinary Trauma & Critical Care Conference 2016 210
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 209
Activation of endogenous retroviruses of the HERV-W family by Epstein Barr virus in vitro and in vivo: a dual virus model as the missing link with multiple sclerosis 206
Accessi alle fratture dell’osso frontale e del basicranio anteriore 205
Analysis of fanconi anemia genes in colorectal cancer 205
Analysis of gene expression of ovine pre-implantation embryos derived from in vitro fertilization and parthenogenetic activation 204
Asymmetric color perception in the shopping aisle: some implications for merchandising 203
A new sutureless technique for end-to-end and end-to-side arterial and prosthetic anastomosis 201
Anthropological investigation on the remains of “Sa Figu” tomb II (Ittiri- Sassari) early bronze age 201
First report of grapevine black rot in Sardinia. 198
A portable device for estimating the somatic cell count in sheep milk 197
Archaeometric analyses on pottery of eneolithic age from central Sardinia. 196
A Founder Mutation In Sardinian Breast Cancer Families Detected By Identity-By-Descent Method 196
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 194
Analysis of the mapk-erk gene pathway in primary and metastatic melanoma cell lines 193
Analisi dei risultati a medio termine delle artrodesi strumentate lombari mediante approccio estremo laterale 193
COMPARATIVE STUDY ON THE USE OF A NON-DESTRUCTIVE OPTICAL SENSOR (MULTIPLEX3®) FOR THE MONITORING OF THE ANTHOCYANINS CONTENT IN RED BERRY FRUITS 193
A First Look at the Italian Registry on Pulmonary Non-Tuberculous Mycobacteria (NTM) -IRENE 192
111In-pentetreotide SPECT/CT for functional anatomical mapping in patients with pulmonary carcinoid. 192
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 188
A NEW SUTURELESS TECNIQUE FOR END-TO-END AND END-TO-SIDE ARTERIAL AND PROSTHETIC ANASTOMOSIS 185
Acute hyponatremia and neuroleptic malignant syndrome 184
Analisi descrittiva degli incidenti da traffico rilevati presso la A.U.S.L. 1 di Sassari nel periodo 1992-1996. 184
Plasma taurine levels in age-related macular degeneration 183
Aesthethic refinements in orthognathic surgery: osteotomy versus implants in malar and chin augmentation 183
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 183
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 183
12. Prolactin (PRL) response to Thyrotropin Releasing Hormone (TRH) in patients with subacute thyroiditis in the early stage. 182
99mTc-tetrofosmin SPECT: a useful diagnostic tool in breast cancer (BC) detection 181
Caratteristiche morfologiche del disco intervertebrale lombare umano normale e patologico. 181
A new disease of Erica arborea in Italy caused by Neofusicoccum luteum 180
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage 179
Brainstem function in multiple sclerosis (MS): clinical, magnetic resonance imaging (MRI) and neurophysiological follow-up 179
Acute respiratory paralysis in arsenic neuropathy following intravenous intoxication 179
1H NMR-based metabolomic analysis of urine from term and preterm neonates 179
Beneficial effect of risperidone on behavioral disturbances associated with hyperostosis frontalis interna 178
18p deletion syndrome: foetal phenotype and cytogenetic characterization 178
An ultrastructural study on the variability of interfacial morphology between a self etching system and carious and sclerotic dentin 178
Analysis of Vermentino plants with symptoms of chlorotic mottling and leaf deformation disease by molecular test and fluorimetric indices 177
A novel candidate gene in human endometrial cancer at chromosome 10q26 177
Antibiotic resistant H-pylori are extremely common in Sardinia. 176
Axillary lymph node dissection in T1a and T1b breast cancer. 176
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 175
123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD) 174
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 173
Analysis of EGFR status in endometrial stromal sarcoma 173
Cadmium induced effects on morphology of glomerul cells of the rat kidney 173
Totale 23.427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021484 0 0 0 0 0 0 0 0 0 0 0 484
2021/20226.733 958 63 29 64 25 57 263 570 573 304 720 3.107
2022/202317.146 1.817 782 257 2.886 1.939 2.940 23 2.074 3.047 142 793 446
2023/20244.968 920 396 252 181 974 399 62 164 3 109 550 958
2024/202549.954 478 391 2.799 775 1.642 1.340 3.096 11.715 18.038 6.657 1.751 1.272
2025/202670.641 2.530 19.792 11.419 9.919 4.962 3.548 8.641 2.133 3.068 2.603 1.732 294
Totale 191.270